Rosenblatt analyst Kevin Cassidy revised estimates for Navitas Semiconductor Corporation (NASDAQ:NVTS) following the first quarter results reported on Monday. The company reported an adjusted EPS loss of 6 cents, which was in line with estimates, and sales reached $14.02 million, exceeding the estimated $13.99 million. Navitas Semiconductor expects second quarter sales of $14 million – $15 million vs consensus of $14.95 million. The analyst says that the results and guidance for the second quarter of 2025 were largely in line with expectations. The analyst adds that the adoption of Gallium Nitride (GaN) technology in end markets beyond handsets continues to be slower than anticipated and is still working through existing Silicon Carbide (SiC) inventory. The analyst writes that the company is securing new design wins, with particular optimism on the recently launched GaN bi-directional diode switch. Cassidy expects production ramps for solar microinverter applications in the second half of 2025. While tariffs are not currently a direct impediment to demand, management expressed caution regarding the second half of 2025 and has contingency plans in place for China-for-China and USA-for-USA, adds the analyst. For FY25, the analyst estimates revenues of $60.5 million (vs. consensus of $74.5 million) and an adjusted EPS loss of $0.19 (vs. consensus loss of $0.16), down from the earlier estimate of $75 million and a loss of $0.16, respectively. For FY26, Cassidy continues to estimate revenue of $110 million and an adjusted EPS loss of $0.07. Price Action: NVTS shares closed lower by 4.74% at $1.91 on Tuesday. Read Next: Canadian Solar Posts Wider Q4 Loss, Reaffirms 2025 Outlook Amid Fierce Industry Headwinds Photo via Shutterstock Latest Ratings for NVTS Date Firm Action From To Feb 2022 Rosenblatt Initiates Coverage On Buy Feb 2022 Needham Initiates Coverage On Buy Dec 2021 B of A Securities Initiates Coverage On Neutral View More Analyst Ratings for NVTS View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Navitas GaN Adoption Is Slower Than Anticipated: Analyst originally appeared on Benzinga.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments
Navitas GaN Adoption Is Slower Than Anticipated: Analyst
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...